Loading...
Atomo Diagnostics Limited
AT1.AX•ASX
Healthcare
Medical - Devices
A$0.02
A$0.00(0.00%)
Atomo Diagnostics Limited (AT1.AX) Financial Performance & Income Statement Overview
Analyze Atomo Diagnostics Limited (AT1.AX) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Revenue Growth
60.65%
↑ 60.65%
Operating Income Growth
56.55%
↑ 56.55%
Net Income Growth
31.23%
↑ 31.23%
Operating Cash Flow Growth
19.86%
↑ 19.86%
Operating Margin
-92.60%
↓ 92.60%
Gross Margin
35.09%
↑ 35.09%
Net Profit Margin
-153.10%
↓ 153.10%
ROE
-73.80%
↓ 73.80%
ROIC
-51.66%
↓ 51.66%
Atomo Diagnostics Limited (AT1.AX) Income Statement & Financial Overview
Analyze Atomo Diagnostics Limited’s AT1.AX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $2.16M | $1.92M | $1.18M | $1.36M |
| Cost of Revenue | $1.59M | $4.21M | $4.04M | $4.58M |
| Gross Profit | $574311.00 | -$2.29M | -$2.86M | -$3.22M |
| Gross Profit Ratio | $0.27 | -$1.19 | -$2.41 | -$2.37 |
| R&D Expenses | $127610.00 | $108813.00 | $220872.00 | $383847.00 |
| SG&A Expenses | $2.28M | $1.32M | $1.58M | $1.78M |
| Operating Expenses | $2.44M | $1.43M | $1.80M | $2.16M |
| Total Costs & Expenses | $4.03M | $5.64M | $5.84M | $6.74M |
| Interest Income | $75246.00 | $76834.00 | $47906.00 | $26203.00 |
| Interest Expense | $3569.00 | $5951.00 | $7021.00 | $7966.00 |
| Depreciation & Amortization | $705400.00 | $833929.00 | $843779.00 | $1.05M |
| EBITDA | -$2.50M | -$2.81M | -$3.78M | -$5.22M |
| EBITDA Ratio | -$1.15 | -$1.50 | -$3.22 | -$3.19 |
| Operating Income | -$1.87M | -$3.71M | -$4.66M | -$5.38M |
| Operating Income Ratio | -$0.86 | -$1.93 | -$3.93 | -$3.96 |
| Other Income/Expenses (Net) | -$2.27M | $67049.00 | $27207.00 | -$892190.00 |
| Income Before Tax | -$4.14M | -$3.65M | -$4.63M | -$6.27M |
| Income Before Tax Ratio | -$1.91 | -$1.90 | -$3.91 | -$4.62 |
| Income Tax Expense | -$443684.00 | -$495419.00 | -$415901.00 | -$530510.00 |
| Net Income | -$3.70M | -$3.15M | -$4.21M | -$5.74M |
| Net Income Ratio | -$1.71 | -$1.64 | -$3.56 | -$4.23 |
| EPS | -$0.006 | -$0.005 | -$0.007 | -$0.01 |
| Diluted EPS | -$0.006 | -$0.005 | -$0.007 | -$0.01 |
| Weighted Avg Shares Outstanding | $639.14M | $628.84M | $570.89M | $570.89M |
| Weighted Avg Shares Outstanding (Diluted) | $639.20M | $628.84M | $570.89M | $570.89M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan